![Recent Advancement of PD-L1 Detection Technologies and Clinical Applications in the Era of Precision Cancer Therapy Recent Advancement of PD-L1 Detection Technologies and Clinical Applications in the Era of Precision Cancer Therapy](https://www.jcancer.org/v14/p0850/toc.jpg)
Recent Advancement of PD-L1 Detection Technologies and Clinical Applications in the Era of Precision Cancer Therapy
![PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma | Virchows Archiv PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma | Virchows Archiv](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00428-020-02751-6/MediaObjects/428_2020_2751_Fig1_HTML.png)
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma | Virchows Archiv
![PD-L1 is a negative prognostic marker for patients with mesothelioma.... | Download Scientific Diagram PD-L1 is a negative prognostic marker for patients with mesothelioma.... | Download Scientific Diagram](https://www.researchgate.net/publication/327275048/figure/fig1/AS:763183572729856@1558968551057/PD-L1-is-a-negative-prognostic-marker-for-patients-with-mesothelioma-PD-L1-expression-in.png)
PD-L1 is a negative prognostic marker for patients with mesothelioma.... | Download Scientific Diagram
Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity | Aging
![Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy | Science Translational Medicine Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aav7431/asset/85e94c2b-fa8d-4a85-8a1e-b8e7e2ae2095/assets/graphic/aav7431-f1.jpeg)
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy | Science Translational Medicine
![Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer - eBioMedicine Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer - eBioMedicine](https://www.thelancet.com/cms/attachment/eaab664f-c9d1-4a8a-af9b-fc8dc335e1e3/gr1_lrg.jpg)
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer - eBioMedicine
![Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors | Scientific Reports Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-10946-2/MediaObjects/41598_2017_10946_Fig1_HTML.jpg)
Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors | Scientific Reports
![Frontiers | PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition Frontiers | PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition](https://www.frontiersin.org/files/Articles/437710/fimmu-10-02022-HTML/image_m/fimmu-10-02022-g001.jpg)
Frontiers | PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
![Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy | PNAS Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy | PNAS](https://www.pnas.org/cms/10.1073/pnas.1921445117/asset/0925d954-bfab-4bb5-896c-5e32c72628b9/assets/graphic/pnas.1921445117fig07.jpeg)
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy | PNAS
![JCI - Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues JCI - Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues](https://dm5migu4zj3pb.cloudfront.net/manuscripts/150000/150846/medium/JCI150846.ga.jpg)
JCI - Targeting HIF-1α abrogates PD-L1–mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues
![Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review) Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)](https://www.spandidos-publications.com/article_images/or/44/2/OR-44-02-0424-g00.jpg)
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
![IJMS | Free Full-Text | PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy IJMS | Free Full-Text | PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy](https://www.mdpi.com/ijms/ijms-21-05918/article_deploy/html/images/ijms-21-05918-g001.png)
IJMS | Free Full-Text | PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
![PD-L1 IHC-staining patterns: expression was noticed in the tumor cells... | Download Scientific Diagram PD-L1 IHC-staining patterns: expression was noticed in the tumor cells... | Download Scientific Diagram](https://www.researchgate.net/publication/298734604/figure/fig2/AS:667900478234624@1536251291067/PD-L1-IHC-staining-patterns-expression-was-noticed-in-the-tumor-cells-A-in.png)